ganciclovir sodium
NDC 70436-231, ganciclovir sodium, injection, powder, lyophilized, for solution, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-231
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-231 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANCICLOVIR SODIUM500 mg/10mL
Pharmacologic classes
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-231-55 | 70436023155 | 25 VIAL in 1 CARTON (70436-231-55) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cd293b9d-b573-4656-8574-19d7db870a9bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70436-231
Use it
Look up 70436-231 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-231 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-231. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.